Led by Director Dr Metodi Metodiev, the unit has uncovered a panel of protein biomarkers which could lead to improved diagnosis of tumour types and fine-tuned treatment.
‘When we set up the Proteomics Unit here we immediately turned our attention to human issues and the treatment of disease,’ said Dr Metodiev.
Each year more than 42,000 people in the UK are diagnosed with breast cancer, 99 per cent of whom are women. Research has highlighted several risk factors associated with the disease, but better markers are needed for diagnosis, prognosis and therapy. The new technology of proteomics, which is the large-scale study of proteins which are vital components of living organisms as well as tumours, promises to deliver breakthroughs into cancer biomarkers.
‘With proteomics, analysis that took a month to perform can now be done in a second. This gives us a lot more information and is bringing about a very significant change to the way we approach cancer,’ said Dr Metodiev.
Working with Dr Louise Alldridge from Anglia Ruskin University, Chelmsford, clinicians from Broomfield Hospital, Chelmsford, and the Breast Unit at Chelmsford and Essex Hospital, the scientists have examined thousands of proteins in tumour and normal human tissue. They have determined a panel of prospective biomarkers and are now narrowing it down to see what patterns emerge, before a large scale clinical trial can be attempted.
Kate Clayton | alfa
Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign
Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences